4 withdrawn. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Withdrawn 4 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Aneurysm: new trials by email Literature Review of Aneurysm trials Research Report on Aneurysm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache Botox 200 UNT Injection, Non Botox based Standard of Care Treatments for Headache/Migraine - Stroke (CVA) or TIA, Headache, Migraine | Phase 1 | Withdrawn | University of Alberta | 2023-12-01 | 2024-09-19 | |
| Canadian eCLIPs™ Safety and Feasibility Study Protocol eCLIPs™ Family of Products - Intracranial Aneurysms | Phase 1 | Withdrawn | Evasc Medical Systems Corp. | 2020-01-01 | 2019-02-08 | |
| Effect of Intraventricular tPA Following Aneurysmal Subarachnoid Hemorrhage Tissue Plasminogen Activator - Subarachnoid Hemorrhage, Cerebral Vasospasm | Phase 1 / Phase 2 | Withdrawn | Rush University Medical Center | 2015-03-01 | 2015-11-11 | |
| A Feasibility Study of the Surpass Aneurysm-Embolization System in Intracranial Arteries Aneurysm-Embolization System - Aneurysm | Phase 1 | Withdrawn | Surpass Medical Ltd. | 10 | 2010-11-30 |
Intracranial Aneurysm (2) · Headache (1) · Hemorrhagic Stroke (1) · Hydrocephalus (1) · Migraine Disorders (1) · Stroke (1) · Subarachnoid Hemorrhage (1) · Vasospasm, Intracranial (1) · Vertebral Artery Dissection (1)
Cardiovascular Diseases (4) · Vascular Diseases (4) · Brain Diseases (3) · Central Nervous System Diseases (3) · Cerebrovascular Disorders (3) · Nervous System Diseases (3) · Intracranial Arterial Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Cerebrovascular Trauma (1) · Dissection, Blood Vessel (1) · Headache Disorders (1) · Headache Disorders, Primary (1) · Hemorrhage (1) · Intracranial Hemorrhages (1)
Tissue Plasminogen Activator (1) · onabotulinum toxin A (1)
Evasc Medical Systems Corp. (1) · Rush University Medical Center (1) · Surpass Medical Ltd. (1) · University of Alberta (1)
Canada (2) · United States (1)
Michael EB Kelly, PhD, MD, FRCSC, FACS (1) · Muzaffar M Siddiqui, MD (1) · Roham Moftakhar, MD (1) · Stephan Munich, MD (1) · Vipul Gupta, MD (1)
PMID 25164919, PMID 25500317, PMID 26381856, PMID 27910097, PMID 29765218, PMID 30152015, PMID 30232673, PMID 30617735